EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinomaYuan Li, Lin‐Quan Tang|Cell Death and Differentiation|2022Cited by 148
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialYuan Li, Hai‐Qiang Mai|Nature Communications|2023Cited by 45